Diabetic Retinopathy


March 6th, 2009 - March 6th, 2012
1.00 AMA PRA Category 1 Credit Hours

Description

According to the National Institutes of Health, Diabetic retinopathy is the leading cause of blindness in working-age Americans. People with both type 1 diabetes and type 2 diabetes are at risk for this condition. This activity is supported in part by educational grants from Merck and Astellas.
The webcast is no longer available.
Post-Test taking for this webcast is no longer available.

Dates and Times

End Date: 3/6/2012

Objectives

Upon completion of this educational activity, the participant will be able to: 1.) Review symptoms and ophthalmoscopic findings of diabetic retinopathy. 2.) Review current treatments and outcome goals for managing diabetic retinopathy.

Webcasts Files

File Link

PDF of Slides

Download

Accreditation

The Center for Continuing Medical Education (CCME) at The Ohio State University is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians

The Center for Continuing Medical Education (CCME) at The Ohio State University designates this webcasts for a maximum of 1.00 AMA PRA Category 1 Credit(s) . Physicians should only claim credit commensurate with the extent of their participation in the activity.